Penumbra, Inc. (PEN)

NYSE: PEN · Real-Time Price · USD

300.66

+5.94 (2.02%)

At close: Dec 5, 2025, 4:00 PM EST

304.41

+3.75 (1.25%)

After-hours: Dec 5, 2025, 7:58 PM EST

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
United States Revenue	1.04B	902.07M	Log In	Log In	Log In	Upgrade
International Revenue	293.17M	292.55M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.33B	1.19B	Log In	Log In	Log In	Upgrade

Revenue Breakdown

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
Thrombectomy Revenue	913.35M	815.48M	Log In	Log In	Log In	Upgrade
Embolization and Access Revenue	420.45M	379.14M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.33B	1.19B	Log In	Log In	Log In	Upgrade

Revenue Breakdown 2

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
Vascular Revenue	-	-	Log In	Log In	Log In	Upgrade
Neuro Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.33B	1.19B	Log In	Log In	Log In	Upgrade